LEM-mR203

N/A

Report date: 2026/05/13 09:17:11

Base Information

Drug NameLEM-mR203

Drug Alias NameLEM-mR203

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesLemonex Inc

China Registration ClassN/A

Develop Information

Active CompaniesLemonex Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A